ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2014

Cost-effectiveness of long-acting injectable risperidone versus flupentixol decanoate in the treatment of schizophrenia: a Markov model parameterized using administrative data.

Simon Frey et al.PubMed ↗Publisher ↗

No numbers read from the abstract.